Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.